Dual submission process

Back

First submission

  1. Submit your (a) draft prospectus and (b) Euronext Dublin Listing Conditions Checklist to debt@euronext.com
  2. Submit your (a) draft prospectus (b) draft non-applicable letter and (c) applicable Prospectus Regulation Annexes to debt@corporatefinance-cbi.ie
  3. You will receive comments from Euronext Dublin and CBI within three business days.

Subsequent submissions

  1. Submit your (a) draft prospectus and (b) replies to Euronext Dublin comments to debt@euronext.com
  2. Submit your (a) draft prospectus (b) draft non-applicable letter and (c) replies to CBI comments to debt@corporatefinance-cbi.ie
  3. You will receive comments from Euronext Dublin and CBI within two business days.

Approval submission

  1. Submit your (a) final prospectus (b) final replies to Euronext Dublin comments (c) Euronext Dublin support documentation and (d) confirmation of payment to debt@euronext.co %6d" rel="nofollow"> debt@euronext.com before 10:00 GMT on the approval date.
  2. Submit your (a) final prospectus (b) final non-applicable letter (c) final replies to CBI comments (d) CBI support documentation and (e) confirmation of payment to debt@corporatefinance-cbi.ie before 10:00 GMT on the approval date.
  3. When the CBI approves your prospectus it will notify you and Euronext Dublin. We will then confirm our approval and your listing and admission to trading.

Exceptions

Final terms
  • Submit to Euronext Dublin at debt@euronext.com before 14:00 GMT one business day prior to listing.
Financial supplements
Non-financial supplements
Short term paper
  • Submit your draft information memorandum to ecp@euronext.com .
  • We will return our comments within two business days of first submission and within one day of subsequent submissions.
  • For approval submit your (a) final information memorandum (b) final replies to Euronext Dublin comments (c) Euronext Dublin support documentation and (d) confirmation of payment to ecp@euronext.com  before 14:00 GMT.

We will confirm our approval, listing and admission to trading